Sewoon Medical Co. Ltd (100700) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Sewoon Medical Co. Ltd (100700) has a cash flow conversion efficiency ratio of 0.019x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩3.11 Billion ≈ $2.11 Million USD) by net assets (₩160.14 Billion ≈ $108.53 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Sewoon Medical Co. Ltd (100700) total market value for the company's overall valuation and market capitalisation.
Sewoon Medical Co. Ltd - Cash Flow Conversion Efficiency Trend (2011–2025)
This chart illustrates how Sewoon Medical Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Sewoon Medical Co. Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Sewoon Medical Co. Ltd ranked by their cash flow conversion efficiency. Explore 100700 cash flow quality index to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Austco Healthcare Ltd
AU:AHC
|
0.216x |
|
Eaton Vance California MIT
NYSE MKT:CEV
|
0.018x |
|
Artifex Mundi SA
WAR:ART
|
-0.016x |
|
Phytohealth Corp
TW:4108
|
-0.001x |
|
Wiener Privatbank SE
VI:WPB
|
-0.423x |
|
Energy Transition Minerals Ltd
AU:ETM
|
-0.101x |
|
Rorze Systems Corporation
KQ:071280
|
0.008x |
|
Pacific Petroleum Transportation JSC
VN:PVP
|
N/A |
Annual Cash Flow Conversion Efficiency for Sewoon Medical Co. Ltd (2011–2025)
The table below shows the annual cash flow conversion efficiency of Sewoon Medical Co. Ltd from 2011 to 2025. View 100700 live share price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | ₩154.40 Billion ≈ $104.64 Million |
₩17.77 Billion ≈ $12.04 Million |
0.115x | +27.56% |
| 2024-12-31 | ₩146.12 Billion ≈ $99.02 Million |
₩13.19 Billion ≈ $8.94 Million |
0.090x | -46.16% |
| 2023-12-31 | ₩137.69 Billion ≈ $93.31 Million |
₩23.08 Billion ≈ $15.64 Million |
0.168x | +122.18% |
| 2022-12-31 | ₩123.01 Billion ≈ $83.36 Million |
₩9.28 Billion ≈ $6.29 Million |
0.075x | -59.90% |
| 2021-12-31 | ₩114.13 Billion ≈ $77.35 Million |
₩21.47 Billion ≈ $14.55 Million |
0.188x | -0.36% |
| 2020-12-31 | ₩101.98 Billion ≈ $69.11 Million |
₩19.25 Billion ≈ $13.05 Million |
0.189x | +33.34% |
| 2019-12-31 | ₩95.22 Billion ≈ $64.53 Million |
₩13.48 Billion ≈ $9.14 Million |
0.142x | +0.25% |
| 2018-12-31 | ₩86.35 Billion ≈ $58.52 Million |
₩12.19 Billion ≈ $8.26 Million |
0.141x | +33.38% |
| 2017-12-31 | ₩77.72 Billion ≈ $52.67 Million |
₩8.23 Billion ≈ $5.58 Million |
0.106x | +21.89% |
| 2016-12-31 | ₩73.09 Billion ≈ $49.53 Million |
₩6.35 Billion ≈ $4.30 Million |
0.087x | +56.05% |
| 2015-12-31 | ₩65.61 Billion ≈ $44.47 Million |
₩3.65 Billion ≈ $2.48 Million |
0.056x | -57.37% |
| 2014-12-31 | ₩64.35 Billion ≈ $43.61 Million |
₩8.40 Billion ≈ $5.69 Million |
0.131x | -20.28% |
| 2013-12-31 | ₩58.72 Billion ≈ $39.80 Million |
₩9.62 Billion ≈ $6.52 Million |
0.164x | +16.78% |
| 2012-12-31 | ₩51.25 Billion ≈ $34.73 Million |
₩7.19 Billion ≈ $4.87 Million |
0.140x | +26.92% |
| 2011-12-31 | ₩46.71 Billion ≈ $31.65 Million |
₩5.16 Billion ≈ $3.50 Million |
0.111x | -- |
About Sewoon Medical Co. Ltd
Sewoon Medical Co., Ltd. engages in the research and development, manufacture, and sale of medical products. Its products include wound drainage systems, urinary catheters and tubes, drainage catheters and tubes, respiratory and tracheal tubes, infusion catheters and tubes, and wound care products. The company also offers unigel, thermosens, epistim, bonastent, and other products. Sewoon Medical … Read more